Federated Hermes, Inc. 13D and 13G filings for Amphastar Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-06 10:23 am Sale | 2024-02-29 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 2,165,071 4.520% | -1,107,690 (-33.85%) | Filing |
| 2024-01-17 2:36 pm Sale | 2023-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 3,272,761 6.830% | -11,456 (-0.35%) | Filing |
| 2023-02-01 09:43 am Sale | 2022-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 3,284,217 6.800% | -180,118 (-5.20%) | Filing |
| 2022-02-14 1:29 pm Purchase | 2021-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 3,464,335 7.240% | 238,452 (+7.39%) | Filing |
| 2022-02-14 1:21 pm Purchase | 2021-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 10,150,000 7.260% | 3,150,000 (+45.00%) | Filing |
| 2021-02-12 3:01 pm Purchase | 2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 7,000,000 5.650% | 7,000,000 (New Position) | Filing |
| 2021-02-12 2:55 pm Purchase | 2020-12-31 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 3,225,883 6.790% | 3,225,883 (New Position) | Filing |